Turner S L, Tiver K W, Boyages S C
Department of Radiation Oncology, Westmead Hospital, N.S.W., Australia.
Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):279-83. doi: 10.1016/0360-3016(93)E0112-J.
To determine the frequency of hypothyroidism (both subclinical and clinical) following external beam radiotherapy to the whole of the thyroid gland in the treatment of squamous cell cancers of the head and neck.
One hundred and four patients who had completed radiotherapy 30 days to 5 years earlier (84 patients) or who were scheduled for radiotherapy (20 patients) had a single measurement of serum-free thyroxine and thyroid stimulating hormone levels between August 1991 and May 1992.
None of the 20 patients assessed prior to treatment showed thyroid dysfunction. Twenty of 84 (23.8%) previously treated patients had subclinical (9.5%) or clinical (14.3%) hypothyroidism. By 5 years, up to 40% of patients may become hypothyroid. Thyroid underactivity was significantly more common in patients having both laryngectomy (including hemi-thyroidectomy) and radiotherapy compared to radiotherapy alone (p < 0.001). Hypothyroidism had not been suspected clinically in any patient tested.
In view of the frequency and potential morbidity of this complication, thyroid function testing should become a routine part of posttreatment follow-up for these patients.
确定头颈部鳞状细胞癌患者接受全甲状腺外照射放疗后甲状腺功能减退(包括亚临床和临床甲状腺功能减退)的发生率。
1991年8月至1992年5月期间,104例患者接受了血清游离甲状腺素和促甲状腺激素水平的单次测量,其中84例患者在30天至5年前完成放疗,20例患者计划接受放疗。
20例治疗前评估的患者均未出现甲状腺功能障碍。84例既往接受治疗的患者中有20例(23.8%)出现亚临床(9.5%)或临床(14.3%)甲状腺功能减退。到5年时,高达40%的患者可能会出现甲状腺功能减退。与单纯放疗相比,接受喉切除术(包括半甲状腺切除术)和放疗的患者甲状腺功能减退明显更为常见(p<0.001)。在接受检测的任何患者中,临床上均未怀疑有甲状腺功能减退。
鉴于这种并发症的发生率和潜在发病率,甲状腺功能检测应成为这些患者治疗后随访的常规组成部分。